Publication

Impacts newsletter edition 14: supply chain management and outsourcing

This edition includes articles on:

Post-merger pharmaceutical supply chain integration

Radical results require radical approaches. Expiring patents, increased government regulations, economic pressures, technological innovation and, most significantly, mergers and acquisitions, add a tremendous amount of complexity and uncertainty to the pharmaceutical industry. Merger and acquisition activity offers significant opportunities to gain shareholder value, but can be a damaging force.

Outsourcing in the pharmaceutical industry: how to do it right

Until now, pharmaceutical companies have tended to focus on technology development and bringing blockbuster drugs to market. Recently, however, cost pressures, expiring patents and increased government regulations have changed the content of many boardroom discussions.